Hidekazu Segawa
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments 7
- Oncology top 5%
- Bone health and treatments 8
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 3
- Rheumatology top 10%
- Eosinophilic Disorders and Syndromes 3
-
- Radiopharmaceutical Chemistry and Applications 4
-
- Click Chemistry and Applications 2
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
-
- Fibroblast Growth Factor Research 2
Hidekazu Segawa
20 papers receiving 957 citations
Peers
Comparison fields: 5 of 71
- Hematology 233
- Oncology 458
- Genetics 145
- Rheumatology 129
- Radiology, Nuclear Medicine and Imaging 180
Countries citing papers authored by Hidekazu Segawa
This map shows the geographic impact of Hidekazu Segawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidekazu Segawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidekazu Segawa more than expected).
Fields of papers citing papers by Hidekazu Segawa
This network shows the impact of papers produced by Hidekazu Segawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidekazu Segawa. The network helps show where Hidekazu Segawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hidekazu Segawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 10 | |
| 2 | 2005 | 165 | |
| 3 | 2005 | 15 | |
| 4 | 2005 | 21 | |
| 5 | 2005 | 20 | |
| 6 | 2005 | 25 | |
| 7 | 2005 | 122 | |
| 8 | 2005 | 7 | |
| 9 | A third-generation bisphosphonate, minodronic acid (YM529), augments the interferon alpha/beta-mediated inhibition of renal cell cancer cell growth both in vitro and in vivo. | 2005 | 26 |
| 10 | 2005 | 198 | |
| 11 | 2005 | 23 | |
| 12 | 2004 | 49 | |
| 13 | 2004 | 27 | |
| 14 | 2004 | 73 | |
| 15 | 2004 | 45 | |
| 16 | 2004 | 111 | |
| 17 | 2004 | 33 | |
| 18 | 2004 | 1 | |
| 19 | 2004 | 1 | |
| 20 | 2003 | 13 |
About Hidekazu Segawa
Hidekazu Segawa is a scholar working on Hematology, Oncology and Genetics, having authored 20 papers that have together received 985 indexed citations. Recurring topics across this work include Bone health and treatments (8 papers), Chronic Myeloid Leukemia Treatments (7 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Eosinophilic Disorders and Syndromes (3 papers), Click Chemistry and Applications (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Fibroblast Growth Factor Research (2 papers). The work is most often cited by research in Hematology (233 citations), Oncology (458 citations) and Genetics (145 citations). Hidekazu Segawa has collaborated with scholars based in Japan, Germany and Brazil. Frequent co-authors include Taira Maekawa, Shinya Kimura, Takeshi Yuasa, Junya Kuroda, Masaki Nogawa, Asumi Yokota, Kiyoshi Sato, Seiji Matsumoto, Hiromi Wada and Yuri Kamitsuji. Their work appears in journals such as Journal of Clinical Investigation, Blood and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.